Establishment of a National Immunization Technical Advisory Group in Cote d'Ivoire: Process and lessons learned
Establishment of a National Immunization Technical Advisory Group in Cote d'Ivoire: Process and lessons learned
复制标题
DOI：
10.1016/j.vaccine.2012.01.066
复制
发表时间：
2012-03-28
期刊：
影响因子：
5.5
通讯作者：
Gessner, Bradford D.
中科院分区：
文献类型：
--
作者：
Blau, Julia;Faye, Papa Coumba;Gessner, Bradford D.
2010年1月，科特迪瓦成为撒哈拉以南非洲第一个符合GAVI资格并建立国家免疫技术咨询小组（NITAG）的国家。科特迪瓦“国家疫苗接种和疫苗独立专家委员会”（CNEIV-CI）的成立是为了加强国家在免疫和疫苗方面基于证据的政策决策的能力。科特迪瓦取得成功的主要原因是强烈的政治意愿、充足的国家专业知识、循序渐进的国家驱动进程以及向卫生部提供的技术援助。挑战包括在社会政治危机中运作，以及一些利益相关者由于与其他现有委员会可能重叠而最初不愿意。在与 SIVAC Initiative 举行多次会议以澄清 NITAG 的职责后，后者迅速解散。 (C) 2012 Elsevier Ltd. 保留所有权利。
In January 2010, Cote d'Ivoire became the first GAVI-eligible country in sub-Saharan Africa to establish a National Immunization Technical Advisory Group (NITAG). The Cote d'Ivoire "National Committee of Independent Experts for Vaccination and Vaccines" (CNEIV-CI) was created to strengthen national capacity for evidence-based policy decisions with regard to immunization and vaccines. The primary reasons for success in Cote d'Ivoire were a strong political will, the availability of sufficient national expertise, a step-by-step country-driven process, and the provision of technical assistance to the Ministry of Health. The challenges included operating within the socio-political crisis, and initial reluctance from some stakeholders due to the potential overlap with other existing committees. The latter rapidly dissolved over the course of numerous meetings held with the SIVAC Initiative to clarify the mandate of a NITAG. (C) 2012 Elsevier Ltd. All rights reserved.